Recommended Global Physical Therapy Rehabilitation Webinars & Conferences
Asia Pacific & Middle East
Vascular Dementia Congress 2027
Welcome Message
Welcome to the 21st World Congress on Vascular Dementia and Neurodegenerative Diseases, taking place on January 25–26, 2027, in Rome, Italy, under the theme “Advancing Insights into Vascular Dementia and Neurodegenerative Disorders.”
We are delighted to welcome researchers, neurologists, physicians, healthcare professionals, scientists, academics, and experts from around the world to this important international gathering. This congress provides a valuable platform for sharing knowledge, discussing recent scientific developments, and exploring innovative approaches to the prevention, diagnosis, treatment, and management of vascular dementia and neurodegenerative disorders.
Through inspiring keynote presentations, scientific sessions, interactive discussions, and opportunities for professional networking, participants will have the chance to exchange ideas and build meaningful collaborations. We look forward to creating an engaging environment that encourages new perspectives and advances research and clinical practice.
We warmly welcome you to Rome, Italy, and look forward to your active participation in making this congress a successful and memorable scientific event.
We wish you an inspiring, informative, and rewarding experience at the 21st World Congress on Vascular Dementia and Neurodegenerative Diseases 2027!
About Vascular Dementia Congress 2027
The 21st World Congress on Vascular Dementia and Neurodegenerative Diseases, also known as Vascular Dementia Congress 2027, is scheduled for January 25–26, 2027, in Rome, Italy, under the theme “Advancing Insights into Vascular Dementia and Neurodegenerative Disorders.” The congress is designed to bring together scientists, neurologists, physicians, researchers, healthcare professionals, academics, students, and industry experts to exchange knowledge and discuss emerging developments in vascular dementia and related neurodegenerative conditions.
The congress will provide a platform for exploring current research, clinical approaches, diagnostic developments, disease mechanisms, neuroimaging, stroke-related cognitive impairment, brain health, and emerging strategies for the prevention and management of dementia. The scientific program is intended to encourage interaction between speakers and participants through presentations and discussions.
Key areas of interest include vascular dementia, neurodegenerative diseases, dementia and cognitive decline, stroke and cerebrovascular disorders, brain aging, neuroimaging, neuropathology, neurological rehabilitation, biomarkers, and innovative therapeutic approaches. Topics related to stroke rehabilitation and brain haemorrhage are also represented within the congress's scientific scope.
The event also offers opportunities for researchers to contribute through oral and poster presentations. According to the congress information, submitted abstracts are subject to peer review, while accepted abstracts may be included in conference proceedings and published through the associated Conference Series journals.
Vascular Dementia Congress 2027 aims to encourage international collaboration, scientific exchange, and multidisciplinary discussion while highlighting advances that can contribute to a better understanding of vascular and neurodegenerative disorders.
Join Vascular Dementia Congress 2027 in Rome, Italy, and be part of an international scientific forum dedicated to advancing research, knowledge, and innovation in vascular dementia and neurodegenerative diseases.
Why Attend Vascular Dementia Congress 2027?
Attending the 21st World Congress on Vascular Dementia and Neurodegenerative Diseases 2027 offers an excellent opportunity to learn about the latest developments in vascular dementia, neurodegenerative disorders, cognitive decline, and related neurological conditions.
Key Reasons to Attend
-
Explore the Latest Research: Discover recent findings, emerging concepts, and innovative research in vascular dementia and neurodegenerative diseases.
-
Learn from Experts: Gain insights from leading researchers, neurologists, physicians, academics, and healthcare professionals through keynote lectures and scientific presentations.
-
Expand Clinical Knowledge: Improve your understanding of current approaches to diagnosis, prevention, treatment, rehabilitation, and long-term management of dementia and related disorders.
-
Discover Emerging Innovations: Learn about advances in biomarkers, neuroimaging, neuropathology, therapeutic strategies, and technologies supporting neurological care.
-
Share Your Research: Present your research through oral or poster presentations and receive valuable feedback from an international scientific audience.
-
Build Professional Connections: Connect with researchers, clinicians, healthcare professionals, students, and industry representatives from different countries and establish new academic and professional collaborations.
-
Encourage Multidisciplinary Exchange: Engage with experts from different fields to gain broader perspectives on the complex relationship between vascular and neurodegenerative disorders.
-
Stay Updated with Global Developments: Understand current trends and challenges in dementia research and neurological healthcare from an international perspective.
-
Experience Scientific Networking in Rome: Combine a valuable academic experience with the opportunity to connect with professionals in Rome, Italy, a major international destination for scientific and cultural exchange.
Join Vascular Dementia Congress 2027 and be part of an international platform dedicated to advancing knowledge, research, and innovation in vascular dementia and neurodegenerative diseases.
Target Audience
The 21st World Congress on Vascular Dementia and Neurodegenerative Diseases 2027 welcomes professionals, researchers, academics, and students interested in vascular dementia, neurodegeneration, cognitive disorders, and neurological healthcare.
Who Should Attend?
- Neurologists and Neuroscientists
- Neurosurgeons and Neurophysicians
- Geriatricians and Psychiatrists
- Dementia and Memory Disorder Specialists
- Neuropsychologists and Psychologists
- Radiologists and Neuroradiologists
- Stroke and Cerebrovascular Specialists
- Rehabilitation and Occupational Therapists
- Nurses and Healthcare Professionals
- Clinical Researchers and Medical Scientists
- Pharmacologists and Pharmaceutical Researchers
- Biomarker and Molecular Biology Researchers
- Neuroimaging and Brain Research Specialists
- Academics, Professors, and Faculty Members
- PhD Scholars and Postgraduate Students
- Medical and Healthcare Students
- Representatives from Pharmaceutical and Biotechnology Companies
- Healthcare Technology and Medical Device Professionals
- Government, Public Health, and Healthcare Policy Professionals
- Hospitals, Research Institutes, and Academic Organizations
- Anyone interested in dementia research, prevention, diagnosis, and treatment
The congress provides a multidisciplinary platform for sharing research, exchanging clinical knowledge, exploring emerging innovations, and developing international collaborations in vascular dementia and neurodegenerative diseases.
Sessions & Tracks
Session 01: Vascular Dementia: Pathophysiology, Risk Factors and Disease Mechanisms
This session will explore the biological, vascular, and neurological mechanisms involved in vascular dementia. Topics will include cerebral small vessel disease, hypertension, diabetes, atherosclerosis, stroke, cerebral ischemia, vascular inflammation, endothelial dysfunction, blood–brain barrier disruption, and white matter injury. Discussions will also examine the interaction between vascular pathology and neurodegenerative processes and identify potential targets for early intervention and prevention.
Session 02: Cerebral Small Vessel Disease and Cognitive Impairment
This session will focus on cerebral small vessel disease as a major contributor to vascular cognitive impairment and dementia. Presentations will address white matter hyperintensities, lacunar infarctions, cerebral microbleeds, enlarged perivascular spaces, vascular lesions, and their relationship with cognitive decline. Emerging imaging techniques and strategies for detecting early cerebrovascular damage will also be discussed.
Session 03: Stroke, Vascular Cognitive Impairment and Dementia
This session will examine the relationship between stroke and subsequent cognitive impairment. Topics will include post-stroke dementia, recurrent stroke, strategic infarctions, silent cerebrovascular lesions, cognitive rehabilitation, prevention of secondary vascular events, and clinical approaches for identifying patients at increased risk of long-term cognitive decline.
Session 04: Neurodegenerative Diseases and Mixed Dementia
This session will explore the overlap between vascular dementia and major neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease dementia, Lewy body dementia, and frontotemporal dementia. Discussions will focus on mixed pathologies, shared disease mechanisms, clinical differentiation, biomarkers, and the challenges involved in diagnosing patients with multiple underlying causes of cognitive impairment.
Session 05: Alzheimer’s Disease and Vascular Contributions
This session will investigate the complex interaction between vascular disease and Alzheimer’s pathology. Topics will include amyloid deposition, tau pathology, cerebral blood flow, vascular dysfunction, blood–brain barrier changes, cardiovascular risk factors, and mixed Alzheimer’s and vascular dementia. The session will also consider opportunities for vascular risk reduction to delay cognitive decline.
Session 06: Biomarkers and Early Diagnosis of Dementia
This session will highlight advances in biomarkers for detecting vascular and neurodegenerative disorders at earlier stages. Discussions will include blood-based biomarkers, cerebrospinal fluid markers, neuroimaging biomarkers, inflammatory markers, genetic indicators, and digital assessment tools. Emphasis will be placed on improving diagnostic accuracy and identifying individuals at risk before significant cognitive deterioration occurs.
Session 07: Neuroimaging in Vascular Dementia and Neurodegeneration
This session will explore the growing role of neuroimaging in dementia research and clinical practice. Topics will include MRI, CT, diffusion imaging, susceptibility-weighted imaging, PET, functional imaging, vascular imaging, and advanced quantitative techniques. Presentations will examine how imaging can support diagnosis, disease monitoring, prognosis, and differentiation between vascular and neurodegenerative pathology.
Session 08: Genetics, Epigenetics and Molecular Mechanisms
This session will examine genetic and molecular factors associated with vascular dementia and neurodegenerative diseases. Topics will include genetic susceptibility, hereditary vascular disorders, epigenetic regulation, gene–environment interactions, molecular signaling pathways, inflammation, oxidative stress, mitochondrial dysfunction, and mechanisms that contribute to neuronal and vascular injury.
Session 09: Prevention and Management of Vascular Dementia
This session will focus on strategies for preventing or slowing vascular cognitive decline. Discussions will cover blood pressure control, diabetes management, lipid management, smoking cessation, physical activity, nutrition, cardiovascular health, stroke prevention, and lifestyle modification. Evidence-based approaches for reducing modifiable dementia risk factors will be explored.
Session 10: Therapeutic Approaches and Emerging Treatments
This session will discuss current and emerging therapeutic strategies for vascular dementia and neurodegenerative disorders. Topics will include pharmacological interventions, vascular risk management, neuroprotective approaches, anti-inflammatory strategies, cognitive therapies, rehabilitation, and investigational treatments. The session will also address challenges in developing effective disease-modifying therapies.
Session 11: Neuroinflammation, Oxidative Stress and Brain Aging
This session will explore the role of chronic inflammation and oxidative stress in vascular and neurodegenerative brain disorders. Presentations will examine microglial activation, inflammatory signaling, oxidative damage, endothelial dysfunction, mitochondrial abnormalities, and age-related changes in brain tissue. Potential therapeutic targets for protecting neurons and vascular structures will also be discussed.
Session 12: Cognitive Assessment, Memory and Behavioral Disorders
This session will address clinical approaches to evaluating cognitive and behavioral changes associated with dementia. Topics will include memory impairment, executive dysfunction, attention, language difficulties, visuospatial problems, mood changes, behavioral symptoms, neuropsychological testing, and digital cognitive assessment. Strategies for early recognition and monitoring of disease progression will be highlighted.
Session 13: Dementia in Aging and Geriatric Neurology
This session will focus on dementia within the context of healthy and pathological aging. Discussions will cover age-related cognitive changes, frailty, multimorbidity, polypharmacy, functional decline, geriatric assessment, and personalized care. The session will emphasize multidisciplinary approaches to improving quality of life among older adults living with dementia.
Session 14: Neurorehabilitation and Cognitive Rehabilitation
This session will explore rehabilitation strategies for patients experiencing cognitive and neurological impairment following stroke or progressive neurodegenerative disease. Topics will include cognitive training, physical rehabilitation, occupational therapy, speech and language therapy, assistive technologies, functional recovery, and personalized rehabilitation programs designed to maintain independence.
Session 15: Nutrition, Lifestyle and Brain Health
This session will examine the influence of nutrition and lifestyle on vascular health, brain aging, and dementia risk. Presentations will address healthy dietary patterns, physical activity, obesity, metabolic health, sleep, stress management, smoking, and other modifiable lifestyle factors. The role of preventive strategies in maintaining cognitive and cardiovascular health will be discussed.
Session 16: Digital Health, Artificial Intelligence and Dementia Care
This session will explore emerging technologies transforming dementia research, diagnosis, monitoring, and care. Topics will include artificial intelligence, machine learning, digital biomarkers, wearable devices, remote monitoring, electronic cognitive assessments, telemedicine, and predictive analytics. Discussions will consider how technology can support personalized and earlier detection of cognitive decline.
Session 17: Clinical Trials and Drug Development
This session will provide insights into the development and evaluation of new therapies for vascular dementia and neurodegenerative diseases. Topics will include clinical trial design, patient selection, biomarkers, outcome measures, safety assessment, precision medicine, regulatory challenges, and lessons from recent therapeutic trials. Emerging opportunities for disease-modifying interventions will also be considered.
Session 18: Dementia Care, Patients, Caregivers and Quality of Life
This session will address the broader social and clinical impact of dementia on patients, families, caregivers, and healthcare systems. Discussions will include person-centered care, caregiver support, communication, psychosocial interventions, independence, quality of life, ethical considerations, and long-term care planning. The session will emphasize holistic approaches to dementia management.
Session 19: Global Challenges and Future Directions in Dementia Research
This session will examine the global burden of vascular dementia and neurodegenerative diseases and the challenges faced by healthcare systems worldwide. Topics will include disparities in diagnosis and treatment, access to neurological care, public health strategies, research priorities, international collaboration, emerging technologies, and opportunities for improving dementia prevention and management globally.
Session 20: Innovations, Breakthroughs and the Future of Neurodegenerative Disease Research
The session will highlight emerging discoveries, innovative technologies, and future directions in vascular dementia and neurodegenerative disease research. Discussions will bring together advances in precision medicine, biomarkers, artificial intelligence, neuroimaging, genetics, therapeutics, prevention, and personalized patient care. This session will provide a forward-looking perspective on how multidisciplinary research and international collaboration can shape the future of dementia diagnosis, treatment, and prevention.
Market Analysis Report
The global vascular dementia landscape is expected to expand significantly in the coming years, driven by population aging, increasing stroke burden, cardiovascular risk factors, and improved recognition of vascular cognitive impairment. A 2026 World Stroke Organization fact sheet estimates that around 17.6 million people were affected by total vascular dementia (including mixed vascular and degenerative dementia) in 2021, and this burden could reach approximately 42.7 million cases by 2050 if current proportions remain constant.
From a commercial and research perspective, the vascular dementia market is also projected to grow. One recent market estimate values the global vascular dementia market at approximately USD 1.9 billion in 2025, with a forecast of USD 2.7 billion by 2032, representing an estimated 5.1% CAGR. Another 2026 forecast estimates the vascular dementia market across the major 7MM markets at USD 1.3 billion in 2025, with continued growth expected through 2036, supported by emerging therapies, improved diagnostics, and increasing disease prevalence.
The broader neurodegenerative disease market provides an even larger opportunity for research, innovation, and investment. It is estimated at USD 62.59 billion in 2026 and projected to reach USD 88.5 billion by 2030, representing a 9.4% CAGR. At the same time, the global economic burden of Alzheimer’s disease and related dementias has been projected to rise from USD 2.8 trillion in 2019 to USD 4.7 trillion by 2030, demonstrating the growing need for effective prevention, diagnostics, treatments, and multidisciplinary research. These trends create a strong future environment for Vascular Dementia Congress 2027, particularly for collaboration among clinicians, researchers, pharmaceutical companies, biotechnology firms, diagnostic developers, and healthcare organizations.
Registration & Abstract Submission
Registration Is Open
Join the 21st World Congress on Vascular Dementia and Neurodegenerative Diseases, taking place on January 25–26, 2027, in Rome, Italy. Secure your participation and become part of an international forum bringing together researchers, clinicians, healthcare professionals, academics, and industry experts.
Register Now: https://vasculardementia.neuroconferences.com/registration.php
Abstract Submission Is Open
Researchers, scientists, physicians, academicians, and young investigators are invited to submit their latest research for Oral and Poster Presentations. Accepted abstracts may be considered for inclusion in the conference proceedings and associated publications, subject to the applicable review process.
Submit Your Abstract: https://vasculardementia.neuroconferences.com/abstract-submission.php
Contact Us
For registration assistance, abstract submission, sponsorship, exhibition opportunities, or general conference inquiries, please contact the organizing team.
Website: https://vasculardementia.neuroconferences.com/
WhatsApp: +44 28 8009 0005
Email: [email protected]
Join us in Rome for Vascular Dementia Congress 2027 and share your research, exchange knowledge, and connect with the global scientific community.
Past Conference Report
Vascular Dementia Congress 2025
The 20th World Congress on Vascular Dementia and Neurodegenerative Diseases is scheduled for July 07-08, 2025, in Zurich, Switzerland — a hub of scientific innovation and excellence in healthcare. This premier global event will spotlight the increasing prevalence of mixed dementia, a complex condition that involves both vascular dysfunction and neurodegenerative pathology, bridging the gap between research, clinical practice, and policy development.
With the theme, “Mixed Dementia: Understanding the Overlap Between Vascular and Neurodegenerative Pathologies,” the congress aims to explore the convergence of cerebrovascular and neurodegenerative diseases, enhancing understanding of their shared risk factors, diagnostic challenges, and therapeutic complexities. The event will provide a unique platform for knowledge exchange, collaborative networking, and multi-disciplinary dialogue, attracting thought leaders, clinical researchers, and industry innovators from around the world.
Past Reports Gallery
To Collaborate Scientific Professionals around the World
Conference Date January 25-26, 2027
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by